282 related articles for article (PubMed ID: 36423303)
1. Engineering bacteria as interactive cancer therapies.
Gurbatri CR; Arpaia N; Danino T
Science; 2022 Nov; 378(6622):858-864. PubMed ID: 36423303
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Biology Approaches in The Development of Engineered Therapeutic Microbes.
Kang M; Choe D; Kim K; Cho BK; Cho S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228099
[TBL] [Abstract][Full Text] [Related]
3. Rapid screening of engineered microbial therapies in a 3D multicellular model.
Harimoto T; Singer ZS; Velazquez OS; Zhang J; Castro S; Hinchliffe TE; Mather W; Danino T
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9002-9007. PubMed ID: 30996123
[TBL] [Abstract][Full Text] [Related]
4. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.
Guo Y; Chen Y; Liu X; Min JJ; Tan W; Zheng JH
Cancer Lett; 2020 Jan; 469():102-110. PubMed ID: 31666180
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-controllable engineered bacteria for cancer immunotherapy.
Abedi MH; Yao MS; Mittelstein DR; Bar-Zion A; Swift MB; Lee-Gosselin A; Barturen-Larrea P; Buss MT; Shapiro MG
Nat Commun; 2022 Mar; 13(1):1585. PubMed ID: 35332124
[TBL] [Abstract][Full Text] [Related]
6. The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering.
Dailey KM; Allgood JE; Johnson PR; Ostlie MA; Schaner KC; Brooks BD; Brooks AE
Future Microbiol; 2021 Mar; 16(5):341-368. PubMed ID: 33754804
[TBL] [Abstract][Full Text] [Related]
7. Programmable bacteria induce durable tumor regression and systemic antitumor immunity.
Chowdhury S; Castro S; Coker C; Hinchliffe TE; Arpaia N; Danino T
Nat Med; 2019 Jul; 25(7):1057-1063. PubMed ID: 31270504
[TBL] [Abstract][Full Text] [Related]
8. Advancements in synthetic biology-based bacterial cancer therapy: A modular design approach.
Arboleda-García A; Alarcon-Ruiz I; Boada-Acosta L; Boada Y; Vignoni A; Jantus-Lewintre E
Crit Rev Oncol Hematol; 2023 Oct; 190():104088. PubMed ID: 37541537
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Biology Medicine and Bacteria-Based Cancer Therapeutics.
Lee J; Keates AC; Li CJ
Methods Mol Biol; 2021; 2323():267-280. PubMed ID: 34086287
[TBL] [Abstract][Full Text] [Related]
10. Cell engineering: How to hack the genome.
Perkel JM
Nature; 2017 Jul; 547(7664):477-479. PubMed ID: 28748939
[No Abstract] [Full Text] [Related]
11. Tweak to Treat: Reprograming Bacteria for Cancer Treatment.
Sieow BF; Wun KS; Yong WP; Hwang IY; Chang MW
Trends Cancer; 2021 May; 7(5):447-464. PubMed ID: 33303401
[TBL] [Abstract][Full Text] [Related]
12. Overloaded and stressed: whole-cell considerations for bacterial synthetic biology.
Borkowski O; Ceroni F; Stan GB; Ellis T
Curr Opin Microbiol; 2016 Oct; 33():123-130. PubMed ID: 27494248
[TBL] [Abstract][Full Text] [Related]
13. Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies.
Raman V; Deshpande CP; Khanduja S; Howell LM; Van Dessel N; Forbes NS
Cell Host Microbe; 2023 Oct; 31(10):1574-1592. PubMed ID: 37827116
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells.
Mansouri M; Fussenegger M
Protein Cell; 2022 Jul; 13(7):476-489. PubMed ID: 34586617
[TBL] [Abstract][Full Text] [Related]
15. Visualization of Anticancer Salmonella typhimurium Engineered for Remote Control of Therapeutic Proteins.
Nguyen VH; Min JJ
Methods Mol Biol; 2016; 1409():135-42. PubMed ID: 26846808
[TBL] [Abstract][Full Text] [Related]
16. A novel balanced-lethal host-vector system based on glmS.
Kim K; Jeong JH; Lim D; Hong Y; Yun M; Min JJ; Kwak SJ; Choy HE
PLoS One; 2013; 8(3):e60511. PubMed ID: 23555984
[TBL] [Abstract][Full Text] [Related]
17. Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy.
Chen W; Zhu Y; Zhang Z; Sun X
Adv Drug Deliv Rev; 2022 Jun; 185():114295. PubMed ID: 35429576
[TBL] [Abstract][Full Text] [Related]
18. Coupling spatial segregation with synthetic circuits to control bacterial survival.
Huang S; Lee AJ; Tsoi R; Wu F; Zhang Y; Leong KW; You L
Mol Syst Biol; 2016 Feb; 12(2):859. PubMed ID: 26925805
[TBL] [Abstract][Full Text] [Related]
19. Direct attachment of nanoparticle cargo to Salmonella typhimurium membranes designed for combination bacteriotherapy against tumors.
Kazmierczak R; Choe E; Sinclair J; Eisenstark A
Methods Mol Biol; 2015; 1225():151-63. PubMed ID: 25253255
[TBL] [Abstract][Full Text] [Related]
20. Engineered Attenuated
Hyun J; Jun S; Lim H; Cho H; You SH; Ha SJ; Min JJ; Bang D
ACS Synth Biol; 2021 Oct; 10(10):2478-2487. PubMed ID: 34525796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
